Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Filing (Form 4)
CFO of Fulgent Genetics, Paul Kim, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 23, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., had 2,670 shares of common stock withheld to cover tax obligations.
- This transaction occurred at a price of $24.06 per share.
- Following the transaction, Kim directly owns 194,820 shares of Fulgent Genetics.
- The tax obligations arose from the vesting of restricted stock units granted on February 23, 2023.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a routine transaction related to tax obligations arising from vested equity compensation.
Key Dates
| Date | Description |
|---|---|
| 02/23/2023 | Date of original grant of restricted stock units. |
| 02/27/2023 | Date of original Form 4 filing reporting the grant of restricted stock units. |
| 02/23/2024 | Date of the tax withholding transaction. |
| 02/27/2024 | Date of the current Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.